Hercules Capital, Inc.

Equities

HTGC

US4270965084

Investment Management & Fund Operators

Real-time Estimate Cboe BZX 10:29:41 2024-04-19 am EDT 5-day change 1st Jan Change
18.38 USD +0.68% Intraday chart for Hercules Capital, Inc. +1.05% +10.14%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. for $100 million. CI
Bluebird bio to Restate Financial Statements; Shares Fall MT
JMP Securities Adjusts Hercules Capital Price Target to $19 From $18, Maintains Market Outperform Rating MT
Sector Update: Health Care Stocks Edge Up Late Monday Afternoon MT
Sector Update: Health Care MT
Bluebird bio Secures $175 Million Term Loan Facility MT
Health Data Vision, Inc. announced that it has received $65 million in funding from Hercules Capital, Inc. CI
Piper Sandler Raises Price Target on Hercules Capital to $20 From $18.50, Maintains Overweight Rating MT
Hercules Capital Posts Increased Q4 Net, Total Investment Income MT
Transcript : Hercules Capital, Inc., Q4 2023 Earnings Call, Feb 15, 2024
Hercules Capital, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Hercules Capital, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Wheat Futures Fall as Russian Export Prices Sink -- Daily Grain Highlights DJ
Hercules Capital Declares Q4 Supplemental Cash Distribution of $0.08 a Share, Payable March 6 to Shareholders of Record Feb. 28 MT
Hercules Capital, Inc. Declares Cash Distribution for the Fourth Quarter 2023, Dividend Payable on March 6, 2024 CI
Hercules Capital Announces New Supplemental Cash Distribution of $0.32 Per Share, Payment on March 6, 2024 CI
Haveli Investments Software Fund I, L.P., a fund managed by Haveli Investment Management LLC entered into an Agreement and Plan of Merger to acquire ZeroFox Holdings, Inc. (NasdaqGM : ZFOX) from Monarch Alternative Capital LP and Others for approximately $150 million. CI
Wells Fargo Adjusts Price Target on Hercules Capital to $18 From $17, Maintains Overweight Rating MT
North American Morning Briefing : Central Bankers -2- DJ
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as Traders Exercise Caution MT
Verona Pharma Secures $400 Million Debt Facility With Oxford Finance, Hercules Capital MT
UBS Initiates Coverage on Hercules Capital With Neutral Rating, $17 Price Target MT
Vida Health, Inc. announced that it has received $28.5 million in funding from Canvas Management Company, L.L.C., Ally Bridge Group, General Atlantic Service Company, L.P., Hercules Capital, Inc. and other investors CI
Hercules Capital's Q3 Net Investment Income Rises MT
Transcript : Hercules Capital, Inc., Q3 2023 Earnings Call, Nov 02, 2023
Chart Hercules Capital, Inc.
More charts
Hercules Capital, Inc. is a specialty finance company. The Company is focused on providing financing solutions to venture capital-backed and institutional-backed companies in a variety of technology, life sciences and sustainable and renewable technology industries. It is structured as an internally managed, non-diversified, closed-end investment company. Its business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments in primarily Structured Debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology related industries at attractive yields. It invests in a range of companies active in the technology industry sub-sectors characterized by products or services that require advanced technologies, including, computer software and hardware, networking systems, semiconductors, semiconductor capital equipment, information technology infrastructure and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
18.25 USD
Average target price
18.67 USD
Spread / Average Target
+2.28%
Consensus
  1. Stock Market
  2. Equities
  3. HTGC Stock
  4. News Hercules Capital, Inc.
  5. Piper Sandler Adjusts Hercules Capital's Price Target to $15.50 From $18.50, Maintains Neutral Rating